Skip to main content

Table 3 Serum lipid profiles of patients with diabetic retinopathy who used or did not use statins and who had or did not have diabetic macular edema (DME)

From: Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy

Variable

DME

No DME

p value

Statin group (no. of patients)

16

54

 

 HbA1c (%)

7.7 ± 1.2

8.2 ± 1.7

0.282

 Total cholesterol (mmol/L)

4.7 ± 1.5

4.3 ± 2.8

0.603

 Triglycerides (mmol/L)

3.0 ± 2.7

1.7 ± 0.9

0.004a

 HDL cholesterol (mmol/L)

0.9 ± 0.3

1.1 ± 0.4

0.033a

 LDL cholesterol (mmol/L)

2.2 ± 0.8

2.1 ± 0.8

0.761

No-statin group (no. of patients)

19

21

 

 HbA1c (%)

7.9 ± 1.6

8.2 ± 1.7

0.649

 Total cholesterol (mmol/L)

5.0 ± 1.2

4.2 ± 1.6

0.092

 Triglycerides (mmol/L)

2.3 ± 1.4

1.9 ± 0.8

0.349

 HDL cholesterol (mmol/L)

1.0 ± 0.4

1.2 ± 0.3

0.219

 LDL cholesterol (mmol/L)

3.2 ± 1.1

2.8 ± 1.3

0.443

  1. DME diabetic macular edema, HDL high-density lipoprotein, LDL low-density lipoprotein
  2. a p value <0.05 (independent t-test)